Overvalued, Reckless, and Shareholder Unfriendly Deals Will Start to Be Replaced By Value-Added, Responsible Mergers and Acquisitions Setting Off the Next Phase of Parabolic Growth in the U.S. Cannabis Sector... read more →
Many Investors Placed Their Bets on the Illinois Cannabis Market, But Michigan is Now Surging, and When All is Said and Done, the Great Lakes State Could Be the Come... read more →
The Pandemic First Hit the U.S. Earlier This Year Forcing Most of the Country Into Lockdown and Soon After, the Cannabis Industry Was Deemed as an Essential Business Legal Sales... read more →
Weekly Recreational Cannabis Sales in Michigan Recently Surpass Medical Sales for the First Time Since the State's Adult Use Market Opened in December 2019 The Newly Public 'Super State Operator'... read more →
Move Over U.S. Pot Stocks, There's a New Player in Town, and According to the Numbers, it Might Be Best MSO of Them All Red White & Bloom (CSE: RWB)... read more →
Cannabis Stocks Are Back in Vogue Following a Lengthy Bear Market, Which Began at the Same Time Canada Legalized Adult-Use Marijuana in October 2018 While the Last 1.5 Years Have... read more →
Surging Investor Demand Continues to Be Concentrated into a Limited Number of Psychedelic Stocks As the Psychedelics Industry Continues to Blossom, the Current Circumstances Have Created a Situation for Investors... read more →
Early Weed Investors and Business Minds are Positioning Themselves in the World of Psychedelic Medicine as the Flow of Smart Money Hits the Market Canopy Growth Founder Bruce Linton and... read more →
The First Drug in the Psychedelics Space, Ketamine-Based Spravato By J&J Was Approved Last Year At $6,700 a Month, Spravato is Expected to Generate Well North of $1.3 Billion Annually... read more →
The Federal Government of Both the U.S. and Canada Have Green-Lit the Burgeoning Psychedelics Industry While Also Placing Extremely High Barriers to Entry Strict Regulations Have Prevented Wannabe Firms from... read more →
